$CVV
CVD EQUIPMENT CORP Stock $cvv

$cvv Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000143774922020531 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$8.119M	$5.809M	$4.656M
YoY Change	87.51%	44.0%	38.32%
Cost Of Revenue	$5.699M	$4.367M	$3.886M
YoY Change	58.51%	43.8%	33.02%
Gross Profit	$2.420M	$1.441M	$769.6K
YoY Change	229.58%	44.53%	73.2%
Gross Profit Margin	29.8%	24.81%	16.53%
Selling, General & Admin	$1.780M	$1.729M	$1.465M
YoY Change	17.2%	4.82%	-16.37%
% of Gross Profit	73.54%	119.96%	190.41%
Research & Development	$518.0K	$569.2K	$310.2K
YoY Change	275.19%	32.14%	-0.24%
% of Gross Profit	21.41%	39.5%	40.31%
Depreciation & Amortization	$135.6K	$151.4K	$251.0K
YoY Change	-13.02%	-10.54%	-3.48%
% of Gross Profit	5.6%	10.5%	32.61%
Operating Expenses	$2.298M	$2.298M	$1.776M
YoY Change	38.7%	10.48%	-13.94%
Operating Profit	$122.0K	-$857.0K	-$1.006M
YoY Change	-113.23%	-20.87%	-37.86%
Interest Expense	$159.00	$0.00	$9.634K
YoY Change	-99.56%	-100.0%	-91.01%
% of Operating Profit	0.13%
Other Income/Expense, Net	$5.437K	$5.621K	$0.00
YoY Change	-91.39%	-97.42%	-100.0%
Pretax Income	$64.00K	-$839.0K	-$997.0K
YoY Change	-98.93%	-157.04%	-33.8%
Income Tax	$65.00	$825.00	$0.00
% Of Pretax Income	0.1%
Net Earnings	$63.54K	-$839.4K	-$997.3K
YoY Change	-98.94%	-157.09%	-33.76%
Net Earnings / Revenue	0.78%	-14.45%	-21.42%
Basic Earnings Per Share	$0.01	-$0.12	-$0.15
Diluted Earnings Per Share	$0.01	-$0.12	-$0.15
COMMON SHARES
Basic Shares Outstanding	6.729M	6.729M	6.725M
Diluted Shares Outstanding	6.741M	6.729M	6.725M

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.88M	$12.16M	$13.27M
YoY Change	-31.93%	125.67%	123.79%
Cash & Equivalents	$11.90M	$12.20M	$13.30M
Short-Term Investments
Other Short-Term Assets	$560.0K	$529.3K	$384.3K
YoY Change	169.45%	14.99%	-14.15%
Inventory	$2.134M	$2.050M	$1.738M
Prepaid Expenses
Receivables	$2.851M	$2.572M	$1.498M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$20.57M	$21.57M	$19.61M
YoY Change	-11.91%	-17.86%	-25.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.81M	$12.33M	$12.20M
YoY Change	3.6%	-0.57%	-2.11%
Goodwill
YoY Change
Intangibles	$205.5K	$205.3K	$191.3K
YoY Change	-2.07%	-12.52%	-26.88%
Long-Term Investments
YoY Change
Other Assets	$9.570K	$9.570K	$9.570K
YoY Change	-58.96%	-58.96%	-58.96%
Total Long-Term Assets	$13.03M	$12.55M	$12.40M
YoY Change	3.39%	-0.9%	-2.73%
TOTAL ASSETS
Total Short-Term Assets	$20.57M	$21.57M	$19.61M
Total Long-Term Assets	$13.03M	$12.55M	$12.40M
Total Assets	$33.60M	$34.12M	$32.01M
YoY Change	-6.55%	-12.34%	-18.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.524M	$1.422M	$1.178M
YoY Change	78.41%	56.15%	134.09%
Accrued Expenses	$2.446M	$1.857M	$1.820M
YoY Change	65.61%	5.16%	8.8%
Deferred Revenue	$1.478M	$3.296M	$720.4K
YoY Change	-1.76%	229.25%	-1.79%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$76.38K	$0.00	$0.00
YoY Change	-95.85%	-100.0%	-100.0%
Total Short-Term Liabilities	$5.524M	$6.575M	$3.719M
YoY Change	-2.68%	-55.32%	-73.66%
LONG-TERM LIABILITIES
Long-Term Debt	$355.6K	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$355.6K	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.524M	$6.575M	$3.719M
Total Long-Term Liabilities	$355.6K	$0.00	$0.00
Total Liabilities	$5.880M	$6.575M	$3.719M
YoY Change	3.59%	-55.32%	-77.51%
SHAREHOLDERS EQUITY
Retained Earnings	$70.38K	$6.845K	$846.2K
YoY Change	-97.68%	-100.23%	-119.2%
Common Stock	$27.65M	$27.53M	$27.44M
YoY Change	1.49%	1.45%	1.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$27.72M	$27.54M	$28.29M
YoY Change
Total Liabilities & Shareholders Equity	$33.60M	$34.12M	$32.01M
YoY Change	-6.55%	-12.34%	-18.36%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	$63.54K	-$839.4K	-$997.3K
YoY Change	-98.94%	-157.09%	-33.76%
Depreciation, Depletion And Amortization	$135.6K	$151.4K	$251.0K
YoY Change	-13.02%	-10.54%	-3.48%
Cash From Operating Activities	-$100.0K	-$808.6K	-$1.420M
YoY Change	-94.2%	187.89%	-9.62%
INVESTING ACTIVITIES
Capital Expenditures	-$183.1K	-$303.2K	$177.1K
YoY Change	93.85%	242.7%	562.03%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$10.00K
YoY Change	-100.0%
Cash From Investing Activities	-$183.1K	-$303.2K	-$194.6K
YoY Change	-100.8%	242.7%	627.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$1.766M
YoY Change			929.08%
Cash From Financing Activities	0.000	0.000	-$1.766M
YoY Change	-100.0%	-100.0%	929.08%
NET CHANGE
Cash From Operating Activities	-100.0K	-808.6K	-$1.420M
Cash From Investing Activities	-183.1K	-303.2K	-$194.6K
Cash From Financing Activities	0.000	0.000	-$1.766M
Net Change In Cash	-283.1K	-1.112M	-$3.381M
YoY Change	-102.35%	105.34%	90.99%
FREE CASH FLOW
Cash From Operating Activities	-$100.0K	-$808.6K	-$1.420M
Capital Expenditures	-$183.1K	-$303.2K	$177.1K
Free Cash Flow	$83.04K	-$505.4K	-$1.597M
YoY Change	-105.09%	162.69%	-0.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6728938
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6728938
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6723438
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6723438
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	7000000.0	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	pure
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-16525
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-2621692
	dei	Entity Address Address Line1 EntityAddressAddressLine1	355 South Technology Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Central Islip
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11722
	dei	City Area Code CityAreaCode	631
	dei	Local Phone Number LocalPhoneNumber	981-7081
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	CVV
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6728938
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12159052	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16651371	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2572192	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1446354	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4255400	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2538373	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	2050405	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1225015	usd
CY2022Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	715599	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	529264	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	493788	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	21566313	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	23070500	usd
CY2022Q2	cvv	Property Plant And Equipment Excluding Construction In Progress Net PropertyPlantAndEquipmentExcludingConstructionInProgressNet	12334374	usd
CY2021Q4	cvv	Property Plant And Equipment Excluding Construction In Progress Net PropertyPlantAndEquipmentExcludingConstructionInProgressNet	12261321	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	205258	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	182838	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9570	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9570	usd
CY2022Q2	us-gaap	Assets Assets	34115515	usd
CY2021Q4	us-gaap	Assets Assets	35524229	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1422072	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1161381	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1857317	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1758939	usd
CY2022Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	0	usd
CY2021Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1765508	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3296062	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1650426	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6575451	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6336254	usd
CY2022Q2	us-gaap	Liabilities Liabilities	6575451	usd
CY2021Q4	us-gaap	Liabilities Liabilities	6336254	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	67289	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	67234	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	27465930	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	27277154	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6845	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1843587	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	27540064	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	29187975	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34115515	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35524229	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5808588	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4034408	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10460820	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7400268	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	4367472	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	3037280	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8253647	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5958834	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	1441116	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	997128	usd
	us-gaap	Gross Profit GrossProfit	2207173	usd
	us-gaap	Gross Profit GrossProfit	1441434	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	569194	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	430754	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	879401	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	741708	usd
CY2022Q2	us-gaap	Selling Expense SellingExpense	332261	usd
CY2021Q2	us-gaap	Selling Expense SellingExpense	229147	usd
	us-gaap	Selling Expense SellingExpense	604940	usd
	us-gaap	Selling Expense SellingExpense	364902	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1396506	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1420151	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2589955	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3036535	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2297961	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	2080052	usd
	us-gaap	Operating Expenses OperatingExpenses	4074296	usd
	us-gaap	Operating Expenses OperatingExpenses	4143145	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-856845	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1082924	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1867123	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2701711	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	12647	usd
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	403	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	30929	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1626	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	-0	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	107000	usd
	us-gaap	Interest Expense InterestExpense	5344	usd
	us-gaap	Interest Expense InterestExpense	214221	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2443418	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2443418	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5621	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	217592	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5621	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	436827	usd
CY2022Q2	cvv	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	18268	usd
CY2021Q2	cvv	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	2554413	usd
	cvv	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	31206	usd
	cvv	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	2667650	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-838577	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1471489	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1835917	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-34061	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	825	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1064	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	825	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1064	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-839402	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	1470425	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1836742	usd
	us-gaap	Net Income Loss NetIncomeLoss	-35125	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6728938
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6684281
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6726990
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6682347
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6728938
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6687229
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6726990
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6682347
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	28287745	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-839402	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	91721	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	27540064	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	22670395	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	1470425	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	62078	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	24202898	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	29187975	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1836742	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	188831	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	27540064	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	24125572	usd
	us-gaap	Net Income Loss NetIncomeLoss	-35125	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	112451	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	24202898	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1836742	usd
	us-gaap	Net Income Loss NetIncomeLoss	-35125	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2443418	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	188831	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	112451	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	402305	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	429195	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1125838	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	99723	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	1717027	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	572101	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	825390	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	173363	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-715599	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-0	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	35476	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-239345	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	260691	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	92798	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	98378	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	384654	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1645636	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	214414	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-392291	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-1815748	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2229033	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1850873	usd
	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	10000	usd
	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	0	usd
	cvv	Payments For Capitalized Patent Costs PaymentsForCapitalizedPatentCosts	47423	usd
	cvv	Payments For Capitalized Patent Costs PaymentsForCapitalizedPatentCosts	-0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	460355	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	118471	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-497778	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-118471	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1765508	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	342095	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1765508	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-342095	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4492319	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2311439	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16651371	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7699335	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12159052	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5387896	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1064	usd
	us-gaap	Interest Paid Net InterestPaidNet	8157	usd
	us-gaap	Interest Paid Net InterestPaidNet	214221	usd
CY2022Q2	cvv	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	8822284	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12200000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16700000	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	7000000.0	usd
CY2022Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	4100000	usd
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	8600000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5809000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4034000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10461000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7400000	usd
	cvv	Contract With Customer Cumulative Catchup Adjustment To Revenue Change In Estimate Of Transaction Price And Input Costs ContractWithCustomerCumulativeCatchupAdjustmentToRevenueChangeInEstimateOfTransactionPriceAndInputCosts	12800000	usd
CY2022Q2	cvv	Estimated Earnings EstimatedEarnings	6151767	usd
CY2022Q2	cvv	Costs And Estimated Earnings On Uncompleted Contracts CostsAndEstimatedEarningsOnUncompletedContracts	14974051	usd
CY2022Q2	cvv	Billings To Date BillingsToDate	13683261	usd
CY2022Q2	cvv	Net Cost In Excess Of Billings NetCostInExcessOfBillings	1290790	usd
CY2022Q2	cvv	Deferred Revenues Related To Contracts DeferredRevenuesRelatedToContracts	331452	usd
CY2022Q2	cvv	Contract Liability In Excess Of Contract Assets ContractLiabilityInExcessOfContractAssets	-959338	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	4255400	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3296062	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1366405	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1030955	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	684000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	194060	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	2050405	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1225015	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	36000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	59000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	91721	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	188831	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	62078	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	112451	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	91721	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	62078	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	188831	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	112451	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	12500
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.81
CY2022Q2	us-gaap	Share Price SharePrice	4.60
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	4.60
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.68	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0179	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	599500
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	297500
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0
CY2020Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	1500000	usd
CY2021Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	7000000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6728938
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6684281
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6726990
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6682347
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2948
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6728938
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6687229
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6726990
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6682347
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	599500
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	557052
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	599500
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	560000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	599500
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	297500
CY2022Q2	us-gaap	Assets Assets	34116000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5809000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-857000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-839000	usd
CY2021Q2	us-gaap	Assets Assets	38920000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4034000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1083000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1471000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10461000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1867000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1836000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7400000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2702000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-34000	usd

Files In Submission

Name	View Source	Status
0001437749-22-020531-index-headers.html	Edgar Link	pending
0001437749-22-020531-index.html	Edgar Link	pending
0001437749-22-020531.txt	Edgar Link	pending
0001437749-22-020531-xbrl.zip	Edgar Link	pending
cvv-20220630.xsd	Edgar Link	pending
cvv20220630_10q.htm	Edgar Link	pending
ex_409741.htm	Edgar Link	pending
ex_409742.htm	Edgar Link	pending
ex_409756.htm	Edgar Link	pending
ex_409757.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
cvv-20220630_cal.xml	Edgar Link	unprocessable
cvv-20220630_lab.xml	Edgar Link	unprocessable
cvv-20220630_pre.xml	Edgar Link	unprocessable
cvv-20220630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cvv20220630_10q_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CVV
CVD EQUIPMENT CORP Stock $cvv

2022 Q3 Form 10-Q Financial Statement

#000143774922020531 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVV CVD EQUIPMENT CORP Stock $cvv

2022 Q3 Form 10-Q Financial Statement

#000143774922020531 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVV
CVD EQUIPMENT CORP Stock $cvv